|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
16 December 2017 |
|
Main ID: |
NCT03277079 |
|
Date of registration:
|
06/09/2017 |
|
Prospective Registration:
|
Yes |
|
Primary sponsor: |
|
|
Public title:
|
Low Dose Statins, Ezetimibe and Nutraceuticals
TACO |
|
Scientific title:
|
Low Dose Statins, Ezetimibe and Nutraceuticals in Coronary Artery Disease Patients Intolerant to High Intensity Statin Treatment (TArget ChOlesterol) |
|
Date of first enrolment:
|
October 1, 2017 |
|
Target sample size:
|
100 |
|
Recruitment status: |
Not yet recruiting |
|
URL:
|
https://clinicaltrials.gov/show/NCT03277079 |
|
Study type:
|
Interventional |
|
Study design:
|
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Single (Participant).
|
|
Phase:
|
Phase 4
|
|
|
Countries of recruitment
|
|
Italy
| | | | | | | |
|
Contacts
|
|
Name:
|
Carlo Gaudio, MD |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Sapienza University |
|
|
Name:
|
Francesco Pelliccia, MD |
|
Address:
|
|
|
Telephone:
|
39064997 |
|
Email:
|
f.pelliccia@mclink.it |
|
Affiliation:
|
|
| |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
Patients with angiographically assessed diagnosis of coronary artery disease
Exclusion Criteria:
Age minimum:
18 Years
Age maximum:
N/A
Gender:
All
|
|
Health Condition(s) or Problem(s) studied
|
|
Coronary Artery Disease
|
|
Intervention(s)
|
|
Drug: statin + ezetimibe
|
|
Drug: statin + ezetimibe + Nutraceuticals
|
|
Primary Outcome(s)
|
|
Therapeutic target
[Time Frame: Up to 3 months]
|
|
Secondary ID(s)
|
|
123/D/2017
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|